Evidence supporting the use of: Oligomeric proanthocyanidins
For the health condition: Diabetic Retinopathy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Oligomeric proanthocyanidins (OPCs) are plant-derived polyphenolic compounds found in foods such as grapes, pine bark, and cocoa. There is some scientific interest in their use for diabetic retinopathy due to their antioxidant, anti-inflammatory, and vascular-protective properties. Preclinical studies have shown that OPCs can reduce oxidative stress and inhibit capillary permeability in animal models of diabetes, which are important mechanisms implicated in the development of diabetic retinopathy. Some small clinical studies and pilot trials have reported improvements in retinal microcirculation and a reduction in retinal hemorrhages or edema when OPCs are used as adjunct therapy; however, these studies are limited by small sample sizes, short durations, and methodological weaknesses.

A few clinical trials (mainly from the 1980s and 1990s) using grape seed or pine bark extracts reported possible benefits in microvascular complications of diabetes, but their findings have not been widely replicated or confirmed in large, high-quality randomized controlled trials. Systematic reviews note a lack of robust evidence and highlight the need for more rigorous research. No major clinical guidelines recommend OPCs for diabetic retinopathy treatment at this time.

In summary, scientific interest exists and some preliminary evidence supports the potential benefit of OPCs for diabetic retinopathy, but the overall evidence quality is low (rated 2/5), and more high-quality clinical research is required before routine use can be recommended.

More about Oligomeric proanthocyanidins
More about Diabetic Retinopathy

Products containing Oligomeric proanthocyanidins

We currently have no products on Vitabase that contain this ingredient.